What Researchers Did
Researchers conducted a randomized, sham-controlled, double-blind trial to evaluate hyperbaric oxygen therapy (HBOT) in 25 children aged 8-15 with persistent post-concussion syndrome.
What They Found
Following 60 daily sessions, the HBOT group (n=15) showed significant improvements in cognitive function, including general cognitive score (d=0.598, p=0.01) and executive function (d=0.739, p=0.003), compared to the sham group (n=10). They also experienced better emotional scores (p=0.04) and reduced hyperactivity (d=0.244, p=0.03), with clinical outcomes correlating with positive brain MRI changes.
What This Means for Canadian Patients
This therapy could offer a new treatment option for Canadian children suffering from long-term post-concussion symptoms, potentially improving their cognitive abilities and daily behavior. Such improvements could significantly enhance their quality of life and functional independence.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this study is its relatively small sample size, which may affect the generalizability of the findings.